The financing totaled $16 million, and was led by BVF Partners and Boulder Ventures. Ambrosia's financing will be used to scale up its drug discovery programs and laboratory operations in Boulder, CO.

Ambrosia Biosciences is a privately held drug discovery company developing orally delivered, small molecule-based therapies for obesity and other metabolic disorders.